Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 27. Januar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8772  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 175421  
   
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocol.
BJU Int
Al-Hammouri T, Brembilla G, Brizmohun M, Tuazon J, Clemente J, Mathew M, Potyka I, Brew-Graves C, Markus J, Giganti F, Parry T, Haider A, Mallett S, Dudderidge T, Barrett T, Attard G, Moore C, Punwani S, CLIMATE Trial Management Group.
PMID: 41582606 [PubMed - as supplied by publisher]


Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis.
Prostate Cancer Prostatic Dis
Saporita I, Calabrese M, Carfi FM, Mogavero A, Puglisi M, Treglia G, Vogl UM, Gillessen S, Pereira Mestre R, Pedrani M, Pecoraro G, Salfi G, Erhart CC, Lin HM, Tortola L, Di Maio M, Tucci M, Buttigliero C, Turco F.
PMID: 41582208 [PubMed - as supplied by publisher]


Trends in mortality among patients with malignant neoplasm of kidney in the United States, 1999-2023: a retrospective study.
BMC Cancer
Hu J, Sun X, Jiang J.
PMID: 41582135 [PubMed - as supplied by publisher]


Remodeling of androgen metabolism network mediated by UGT2B: a new perspective on treatment resistance in prostate cancer.
Eur J Pharmacol
Wang Y, Tu C, Qin H, Ma Y, Yang Y, Xiong Y, Peng L, Zhang L.
PMID: 41581721 [PubMed - as supplied by publisher]


Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials.
BMC Pharmacol Toxicol
Gilbert DC, Langley RE, Ayadi D, Berhanu M, Hemanth LK, Kwon S, Abdallah H, Meade A, Clarke N, Gillessen S, James N, Bouche G, Parmar M, Nankivell M, Murphy L.
PMID: 41580831 [PubMed - as supplied by publisher]


Comparison of Cancer Detection Between Transrectal and Transperineal Prostate Biopsy in an Active Surveillance Cohort.
Eur Urol Focus
Nalavenkata SB, Tin AL, Gaffney CD, Liso N, Fainberg J, Patel MI, Vickers AJ, Ehdaie B.
PMID: 41580346 [PubMed - as supplied by publisher]


Reply to the Harry Herr's Letter to the Editor re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014.
Eur Urol
Cabrera C, Buisan O, Servian P.
PMID: 41580335 [PubMed - as supplied by publisher]


Prostatic Adenocarcinoma Identified on Transurethral Resection of Bladder Tumor: A Clinicopathologic Series of a Diagnostically Relevant Potential Pitfall.
Hum Pathol
Wu DJ, Pacheco R, Chan E, Lowe AC, Sangoi AR.
PMID: 41580206 [PubMed - as supplied by publisher]


International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative Radiotherapy.
Int J Radiat Oncol Biol Phys
Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A.
PMID: 41580163 [PubMed - as supplied by publisher]


Efficacy and safety of tislelizumab plus intravesical chemotherapy in recurrent high-risk non-muscle-invasive bladder cancer: A retrospective single-center real-world study.
Urol Oncol
Chen Q, Wu R, Zhang C, Xie J, Wang Y, Yu X, He W, Wang M, Zhao J, Zhang Z, Zeng S, Xu C.
PMID: 41579586 [PubMed - as supplied by publisher]


An exploratory study on the relationship between renal cell carcinoma and CAFs infiltration by integrating Pathomics and collagen features.
Transl Oncol
Wang R, Jiang M, Li Z, Zhao Z, Shen J.
PMID: 41579564 [PubMed - as supplied by publisher]


Holmium laser en‑bloc vs bipolar and conventional monopolar TURBT for non‑muscle‑ınvasive bladder cancer.
Int Urol Nephrol
Aykaç A, Kaya C, Sungur M, Ayd, Sungur S.
PMID: 41579322 [PubMed - as supplied by publisher]


The importance of targeted plus perilesional prostate biopsy in prostate cancer management (diagnosis and treatment)-real world evidence of a tertiary centre.
Int Urol Nephrol
Bastos SS, Oliveira V, Dias J, Xambre L, Sabença A, Maciel R, Lourenço M, Peralta J.
PMID: 41579321 [PubMed - as supplied by publisher]


Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?
Fam Cancer
Edmunds K, Arora S, Teppala S, Scuffham P, Fairbairn D, Roberts MJ, Horvath L, Smith DP, Tuffaha H.
PMID: 41579216 [PubMed - in process]


Event-free survival and complete response rate as surrogate endpoints for overall survival in high-risk non-muscle-invasive bladder cancer: A meta-analysis of bacillus Calmette-Guérin-naive or -remote cases.
Cancer
Bhattacharya R, Kponee-Shovein K, Gao Y, Song Y, Liu J, Wei K, Kapadia E, Li H, Kamat AM.
PMID: 41579061 [PubMed - indexed for MEDLINE]


PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.
Genes Chromosomes Cancer
Kluth M, Plage H, Furlano K, Hofbauer S, Weinberger S, Fendler A, Ralla B, Schallenberg S, Elezkurtaj S, Lennartz M, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Adamini N, Weischenfeldt J, Zecha H, Simon R, Sauter G, Schlomm T, Horst D, Minner S.
PMID: 41578916 [PubMed - indexed for MEDLINE]


Tumor-Bearing Kidneys as Potential Donors: A National Survey From the United Kingdom.
Exp Clin Transplant
Janahi F, Aslam MZ, Trail M, Brown T, Thwaini A.
PMID: 41578746 [PubMed - indexed for MEDLINE]


Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.
Cancer Rep (Hoboken)
Kawahara T, Nagumo Y, Yamaguchi A, Hamada K, Tanuma K, Nitta S, Shiga M, Ikeda A, Kandori S, Hoshi A, Nishiyama H.
PMID: 41578675 [PubMed - indexed for MEDLINE]


Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience.
Ann Med
Wu J, Cao CZ, Cui HL, Chen MX, Gao LN, Zheng S, Zhou AP, Guan YY, Bi XG, Shi HZ, Shou JZ.
PMID: 41578672 [PubMed - indexed for MEDLINE]


Causal association between socioeconomic disparities and tumors of the urinary system: A Mendelian randomization study.
Medicine (Baltimore)
Chen WW, Wu B, Wen X.
PMID: 41578463 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 175421    Seite 1 von 8772  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1